By Eric J. Kemnitzer Pharmaceutical Cannabis Expansion, Global Contracts & a $1M Market Cap? When something smells this good, you don’t ignore it… At BFCVC 3 , CEO Gabe Diaz  delivered one of the most confident, fundamentals-driven presentations we’ve seen in a long time. And let me tell you, this one was hotter than a fresh basket of Barbill wings straight out of the kitchen. Medcana (OTCID: SFWJ ) isn’t a concept company. It’s not a shell. It’s not hype. It’s operational. F

Why XRP May Continue Bleeding, Gold and Silver Indicators, Epstein's Involvement and Why Congress Holds the Hammer by Eric J. Kemnitzer Crypto rarely breaks cleanly. It stretches… frays… and eventually snaps. Right now, XRP remains tied to Bitcoin by an invisible liquidity tether, not because it belongs there, but because markets still treat “crypto” as one trade. That tether has little to do with Ripple’s real-world progress and everything to do with regulatory ambiguity and

By Eric J. Kemnitzer In an industry often shaped by speculation and binary outcomes, PurMinds is taking a different path. During a recent visit to the company’s Burlington, Ontario facility, we sat down with Angelo Pizzuto, COO of PurMinds, to discuss how the company is approaching growth, capital discipline, and long-term value creation. Rather than emphasizing near-term catalysts or promotional milestones, the conversation focused on execution — how PurMinds is building an